Cargando…
Malignant Melanoma Treated with Topical Imiquimod: A Bespoke Treatment That Spared the Amputation
Surgical excision represents the primary treatment for malignant melanoma. On occasion, however, surgery may not be possible, and a different approach is required. Imiquimod is a Toll-like receptor 7 agonist involved in the activation of the innate immune system. We report the case of a 77-year-old...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
S. Karger AG
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381895/ https://www.ncbi.nlm.nih.gov/pubmed/30792637 http://dx.doi.org/10.1159/000496052 |